A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome
Titel:
A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome
Auteur:
Gallagher, James Fisher, Charles Sherman, Bruce Munger, Mark Meyers, Bruce Ellison, Travis Fischkoff, Steven Barchuk, William T. Teoh, Leah Velagapudi, Raja